Trafalgar International (GCAN) FCF Margin (2017 - 2021)
Greater Cannabis Company (GCAN) posted quarterly FCF Margin of 299.22% for Q2 2021, down 13313.0% year-over-year from N/an in Q2 2020, and down 80.16% quarter-over-quarter from 166.09% in Q2 2020.
Trafalgar International (GCAN) FCF Margin (2017 - 2021) Analysis & Trends
Greater Cannabis Company's FCF Margin history runs 5 years deep, the most recent figure standing at 299.22% for Q2 2021.
- In Q2 2021, FCF Margin fell 13313.0% year-over-year to 299.22%; the TTM figure through Dec 2021 stood at 1864.08% (down 131287.0% YoY), while the FY2021 annual figure was 1864.08%, down 126124.0% from the prior year.
- FCF Margin for Q2 2021 stood at 299.22%, down from 166.09% in the prior quarter.
- The five-year high for FCF Margin was 107.62% in Q1 2018, with the low at 19098.63% in Q2 2017.
- The 5-year median for FCF Margin is 299.22% (2021), against an average of 3358.25%.
- The sharpest annual moves came in 2018 and 2019: FCF Margin surged 1919797 bps in 2018, then plunged 43875 bps in 2019.
- Greater Cannabis Company's FCF Margin stood at 9021.32% in 2017, then surged by 100 bps to 32.05% in 2018, then tumbled by 1369 bps to 470.8% in 2019, then soared by 65 bps to 166.09% in 2020, then slumped by 80 bps to 299.22% in 2021.
- Business Quant data shows GCAN's FCF Margin at 299.22% in Q2 2021, 166.09% in Q2 2020, and 470.8% in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -299.22% |
| Jun 30, 2020 | -166.09% |
| Dec 31, 2019 | -470.80% |
| Sep 30, 2019 | -1,343.09% |
| Dec 31, 2018 | -32.05% |
| Jun 30, 2018 | 99.34% |
| Mar 31, 2018 | 107.62% |
| Sep 30, 2017 | -9,021.32% |
| Jun 30, 2017 | -19,098.63% |